Kamil Ali-Jackson

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern, PA
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kamil Ali-Jackson:

Insider Reports Filed by Kamil Ali-Jackson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PDSB PDS Biotechnology Corp Jun 24, 2024 1 $0 4 Jun 25, 2024 Director
RIGL RIGEL PHARMACEUTICALS INC May 25, 2024 2 $0 4 May 29, 2024 Director
PDSB PDS Biotechnology Corp Jul 14, 2023 1 $0 4 Jul 17, 2023 Director
RIGL RIGEL PHARMACEUTICALS INC May 26, 2023 2 $0 4 Jul 12, 2023 Director
PDSB PDS Biotechnology Corp Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
RIGL RIGEL PHARMACEUTICALS INC May 20, 2022 2 $0 4 May 23, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jan 3, 2022 8 $0 4 Jan 5, 2022 Chief Legal Officer
RIGL RIGEL PHARMACEUTICALS INC Dec 16, 2021 1 $0 4 Dec 17, 2021 Director
RIGL RIGEL PHARMACEUTICALS INC Dec 16, 2021 0 $0 3 Dec 17, 2021 Director
PDSB PDS Biotechnology Corp Jun 15, 2021 2 $100K 4 Jun 17, 2021 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 1 -$208K 4 Jun 4, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. Jun 1, 2021 8 -$997K 4 Jun 2, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. May 6, 2021 8 -$261K 4 May 7, 2021 Chief Legal Officer
ACRS Aclaris Therapeutics, Inc. Mar 11, 2021 1 $0 4 Nov 22, 2021 Chief Legal Officer